TG Therapeutics Looks To Market Ublituximab On Convenience, Pricing In MS

 
• By Alaric DeArment
  
Multiple Sclerosis
TG announces strong top-line Phase III data for ublituximab in multiple sclerosis. • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Immunological

More from Therapeutic Category